ESC Premium Access

24-month results and technical approach of catheter-based renal denervation in patients with resistant hypertension

Congress Session

About the speaker

Associate Professor Daniil Maximkin

Peoples Friendship University of Russia (RUDN University), Moscow (Russian Federation)
0 follower

3 more presentations in this session

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Thumbnail

Potential therapeutic efficacy via avB3-integrin dependent interaction of developmental endothelial locus-1 (Del-1) after established angiotensin-II dependent hypertension

Speaker: Mr M. Amponsah-Offeh (Dresden, DE)

Thumbnail

Protective effects of renal denervation based on MRI assessment of the brain in patients with resistant hypertension

Speaker: Doctor A. Sukhareva (Tomsk, RU)

Thumbnail

Access the full session

Recent advances in diagnosis/treatment of hypertension

Speakers: Associate Professor D. Maximkin, Doctor P. Kolkhof, Mr M. Amponsah-Offeh, Doctor A. Sukhareva
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes

27 August 2021

ESC Premium Access

The novel ageing-induced long non-coding RNA MIRIAL controls endothelial cell and mitochondrial function

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by

logo Novo Nordisk